StreetInsider.com News Articles

Burcon Announces Shareholder Meeting Results and Updates Commercial Guidance

Thu, 24 Sep 2026 16:19:00 -0400

Customer demand remains strong as Company accelerates investment in manufacturing infrastructure and reliability

Vancouver, British Columbia--(Newsfile Corp. - September 24, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, today announced the results of its Annual General and Special Meeting of Shareholders (the "Meeting") and provided an update to its commercial guidance.

Annual General and Special Meeting Results

All of the six nominees set out in Burcon's amended and restated management proxy circular dated September 4, 2026 proposed by management for election to the board of directors at the Meeting were elected to

Burcon Announces Shareholder Meeting Results and Updates Commercial Guidance

Thu, 24 Sep 2026 16:19:00 -0400

Customer demand remains strong as Company accelerates investment in manufacturing infrastructure and reliability

Annual General and Special Meeting Results

Burcon Announces Shareholder Meeting Results and Updates Commercial Guidance

Thu, 24 Sep 2026 16:19:00 -0400

Customer demand remains strong as Company accelerates investment in manufacturing infrastructure and reliability

Annual General and Special Meeting Results

Burcon Announces Shareholder Meeting Results and Updates Commercial Guidance

Thu, 24 Sep 2026 16:19:00 -0400

Customer demand remains strong as Company accelerates investment in manufacturing infrastructure and reliability

Annual General and Special Meeting Results

Burcon Announces Annual General and Special Meeting Date

Fri, 04 Sep 2026 16:31:00 -0400

Company upsizes convertible debenture financing from $8.1 million to $21 million following strong investor interest

Vancouver, British Columbia--(Newsfile Corp. - September 4, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce its annual general and special meeting of shareholders (the "AGSM") will be held virtually on September 24, 2026.

Burcon has filed the meeting materials on www.sedarplus.ca in connection with its AGSM to be held on September 24, 2026. The AGSM that had originally been scheduled for September 16, 2026 has now been postponed

Burcon Announces Annual General and Special Meeting Date

Fri, 04 Sep 2026 16:31:00 -0400

Company upsizes convertible debenture financing from $8.1 million to $21 million following strong investor interest

Burcon Announces Annual General and Special Meeting Date

Fri, 04 Sep 2026 16:31:00 -0400

Company upsizes convertible debenture financing from $8.1 million to $21 million following strong investor interest

Burcon Announces Annual General and Special Meeting Date

Fri, 04 Sep 2026 16:31:00 -0400

Company upsizes convertible debenture financing from $8.1 million to $21 million following strong investor interest

Burcon Reports Fiscal 2027 First Quarter Results, Advances Commercial Revenue Ramp

Wed, 12 Aug 2026 16:18:00 -0400

Revenue of $1.3 million, up 273% year-over-year and 54% sequentially

Vancouver, British Columbia--(Newsfile Corp. - August 12, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, reported results for the three months ended June 30, 2026.

"Burcon generated a 54% sequential increase in revenue in the quarter ended June 30, 2026, demonstrating accelerating demand for our solutions. We are seeing market dynamics that reflect something much bigger than our initial growth plan - the protein market is shifting in a direction that plays directly to Burcon's strengths," said Kip Underwood, Chief

Burcon Reports Fiscal 2027 First Quarter Results, Advances Commercial Revenue Ramp

Wed, 12 Aug 2026 16:18:00 -0400

Revenue of $1.3 million, up 273% year-over-year and 54% sequentially

Burcon Announces Fiscal Year 2027 First Quarter Conference Call and Presentation to be Held on August 12, 2026

Fri, 07 Aug 2026 16:05:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - August 7, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, will hold an investor conference call and webcast on Wednesday, August 12, 2026 at 5:00 p.m. Eastern time to discuss its financial results for the first quarter of fiscal year 2027. The Company's financial results will be issued in a press release prior to the call.

A link to the webcast of the conference call is available on Burcon's website under "Presentations" or directly here. The webcast will also be archived for future

Burcon Announces Fiscal Year 2027 First Quarter Conference Call and Presentation to be Held on August 12, 2026

Fri, 07 Aug 2026 16:05:00 -0400

A link to the webcast of the conference call is available on Burcon's website under "Presentations" or directly here. The webcast will also be archived for future

Burcon Announces Fiscal 2026 Results

Wed, 24 Jun 2026 16:11:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - June 24, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, reported results for the fiscal year ended March 31, 2026.

"Fiscal 2026 marked Burcon's transition from technology development to commercial execution," said Kip Underwood, Chief Executive Officer of Burcon. "During the year, we commissioned our production facility, achieved first commercial production and sales across our pea, canola and fava protein platforms, secured commercial agreements and expanded our customer pipeline. We also experienced growing commercial adoption of our protein ingredients, reflected in increasing sales activity and

Burcon Announces Fiscal 2026 Results

Wed, 24 Jun 2026 16:11:00 -0400

Burcon Announces Fiscal Year 2026 Conference Call and Presentation to be Held on June 24, 2026

Fri, 19 Jun 2026 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - June 19, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, will hold an investor conference call and webcast on Wednesday, June 24, 2026 at 5:00 p.m. Eastern time to discuss its financial results for the fiscal year ended March 31, 2026. The Company's financial results will be issued in a press release prior to the call.

"We are pleased to provide shareholders with an update on our fiscal 2026 results and the progress we have made in advancing Burcon's commercialization strategy. Growing customer adoption, increasing

Burcon Announces Fiscal Year 2026 Conference Call and Presentation to be Held on June 24, 2026

Fri, 19 Jun 2026 08:00:00 -0400

"We are pleased to provide shareholders with an update on our fiscal 2026 results and the progress we have made in advancing Burcon's commercialization strategy. Growing customer adoption, increasing

Burcon Accelerates Growth & Achieves New Production Record

Tue, 16 Jun 2026 08:00:00 -0400

Advancing Burcon's commercialization journey through growing commercial traction and manufacturing scale

Vancouver, British Columbia--(Newsfile Corp. - June 16, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based proteins, today announced continued commercial and operational momentum, highlighted by strong growth in sales compared to the previous quarter and the establishment of a new production record with its manufacturing partner, marking another milestone in Burcon's transition from technology development to commercial-scale ingredient sales.

"Approximately 50% growth in sales compared to the previous quarter, combined with record production performance, reflects the continued transition of Burcon from technology

Burcon Accelerates Growth & Achieves New Production Record

Tue, 16 Jun 2026 08:00:00 -0400

Advancing Burcon's commercialization journey through growing commercial traction and manufacturing scale

"Approximately 50% growth in sales compared to the previous quarter, combined with record production performance, reflects the continued transition of Burcon from technology

Burcon appoints Chris Bunio to board, two directors depart

Wed, 29 Apr 2026 17:23:15 -0400

Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) announced the appointment of Chris Bunio to its board of directors. The Vancouver-based plant-based protein company also reported the departure of directors Jeanne McCaherty and Richard Nazur Jr.

Bunio serves as co-founder and CEO of TheoryMesh, a Winnipeg-based company focused on agriculture and food supply chain technology. He established TheoryMesh in 2021 to develop traceability solutions using blockchain and machine learning technologies.

Prior to founding TheoryMesh, Bunio worked at Microsoft for 18 years in strategy, sales and business development roles as a senior director. His responsibilities included covering public sector industries such as government, healthcare

Burcon Announces Appointment of New Director

Wed, 29 Apr 2026 17:21:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - April 29, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) (the "Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce the appointment of Mr. Chris Bunio to the board of directors (the "Board") of Burcon.

Mr. Bunio has been active in the technology industry for nearly 30 years. Mr. Bunio is a Co-founder and the CEO of TheoryMesh, a Winnipeg, Manitoba-based company focused on agriculture and food supply chains. He operationalized TheoryMesh in 2021 to develop technology for traceability solutions leveraging blockchain and machine learning.

Burcon Announces Appointment of New Director

Wed, 29 Apr 2026 17:21:00 -0400

Burcon closes $6.9 million convertible debenture financing

Mon, 27 Apr 2026 08:04:23 -0400

Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) completed the final tranche of its non-brokered private placement of convertible debentures, raising the full targeted amount of $6.9 million.

The Vancouver-based plant-based protein company issued convertible debentures worth $2.9 million in the final tranche. An insider subscribed for approximately $1.7 million of this amount. Total insider participation across all tranches reached approximately $4.4 million in principal amount.

The company received approximately $2.35 million in cash from the final tranche after offsetting $546,678 from amounts owed to an entity related to an insider subscriber. Originally, the company had expected $2.9 million of the placement to

Burcon Closes Final Tranche of Non-Brokered Private Placement of Convertible Debentures of up to $6.9 Million

Mon, 27 Apr 2026 07:58:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - April 27, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce the closing of the final tranche of its previously announced non-brokered private placement (see news releases of the Company dated January 2, 2026, January 9, 2026 and February 27, 2026) of convertible debentures (the "Convertible Debentures") for an aggregate principal amount of $6.9 million (the "Private Placement").

Under the final tranche, Burcon issued Convertible Debentures in the aggregate principal amount of $2.9 million. An insider of the Company subscribed

Burcon Closes Final Tranche of Non-Brokered Private Placement of Convertible Debentures of up to $6.9 Million

Mon, 27 Apr 2026 07:58:00 -0400

Under the final tranche, Burcon issued Convertible Debentures in the aggregate principal amount of $2.9 million. An insider of the Company subscribed

Burcon Achieves Record Production, Expands to More than 20 Buying Customers and Evaluates Additional Capacity Expansion

Mon, 20 Apr 2026 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based proteins, today announced recent operational and commercial milestones demonstrating accelerating momentum in its scale-up and commercialization strategy.

Over the past several weeks, the Company achieved record production, increasing average daily output by approximately 40% as compared to the calendar Q1 average, which proves production capability needed to achieve 2026 goals. In response to growing demand, Burcon and its manufacturing partner, RE ProMan LLC, are evaluating additional capacity expansion opportunities to support future customer requirements.

Burcon has